Aquarius Equity Partners Ltd.

74 Gartside Street, Spinningfields,
Manchester, M3 3EL
United Kingdom,
+44 (0) 161 837 6200

Aquarius Equity Partners is private equity manager focused on high-growth businesses. The Firm manages a variety of funds, from seed stage (investments up to £350,000) to later-stage transactions (investments up to £5 million). The Firm's later-stage fund looks for opportunities in pharmaceuticals, biotechnology, medical devices, specialty chemicals and environmental technology. Aquarius was formed in 2005 and is based in Manchester.

M&A Summary

Buy vs Sell

Top M&A Advisors

Join Mergr to view the latest updates and news from Manchester-based Aquarius Equity Partners.

Aquarius Equity Partners’ most common sectors for investment are life science (84%) and medical products (17%). The Firm’s most common investment types include growth capital (50%) and buyout (lbo, mbo, mbi) (34%).

In the last 3 years, Aquarius Equity Partners has exited 2 companies. The Firm’s most common exit type is trade sale (50%). Aquarius Equity Partners’ largest (disclosed) exit occurred in 2014 when it sold Brabant Pharma for $20M.

Join Mergr to view Aquarius Equity Partners’ full profile and discover more small private equity firms just like it.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.